{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:03:59Z","timestamp":1779771839215,"version":"3.53.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.amjmed.2026.02.048","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:06:53Z","timestamp":1772582813000},"page":"867-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2025"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-719X","authenticated-orcid":false,"given":"Carl A.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Wieland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari L.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terin T.","family":"Sytsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Nadir","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majken T.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amjmed.2026.02.048_bib0001","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa2405404","article-title":"Male-partner treatment to prevent recurrence of bacterial vaginosis","volume":"392","author":"Vodstrcil","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2026.02.048_bib0002","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-021-02077-3","article-title":"Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment","volume":"19","author":"Vodstrcil","year":"2021","journal-title":"BMC Med"},{"issue":"20","key":"10.1016\/j.amjmed.2026.02.048_bib0003","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2026.02.048_bib0004","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amjmed.2026.02.048_bib0005","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMoa2505669","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes","volume":"393","author":"Rosenstock","year":"2025","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.amjmed.2026.02.048_bib0006","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjmed.2026.02.048_bib0007","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/pm\/pnaf089","article-title":"Pain relief by targeting nonrestorative sleep in fibromyalgia: a phase 3 randomized trial of bedtime sublingual cyclobenzaprine","volume":"27","author":"Lederman","year":"2026","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.amjmed.2026.02.048_bib0008","first-page":"72","article-title":"Patterns of pharmacologic and non-pharmacologic treatment, treatment satisfaction and perceived tolerability in patients with fibromyalgia: a patients' survey","volume":"38 Suppl 123","author":"Rico-Villademoros","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.amjmed.2026.02.048_bib0009","article-title":"In the end: associations between sleep disturbance and functional impairment in fibromyalgia-A path analysis study","author":"Bothelius","year":"2025","journal-title":"J Sleep Res"},{"issue":"8","key":"10.1016\/j.amjmed.2026.02.048_bib0011","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S2215-0366(25)00194-4","article-title":"Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK","volume":"12","author":"Browning","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.amjmed.2026.02.048_bib0012","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.amjmed.2026.02.048_bib0013","first-page":"16","article-title":"Medications for treatment-resistant depression in adults","volume":"103","author":"Arnold","year":"2021","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.amjmed.2026.02.048_bib0014","first-page":"410","article-title":"Depression: managing resistance and partial response to treatment","volume":"109","author":"Gaddey","year":"2024","journal-title":"Am Fam Physician"},{"issue":"10480","key":"10.1016\/j.amjmed.2026.02.048_bib0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.amjmed.2026.02.048_bib0016","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mahe","year":"2025","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.amjmed.2026.02.048_bib0017","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","article-title":"Apixaban for extended treatment of provoked venous thromboembolism","volume":"393","author":"Piazza","year":"2025","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.amjmed.2026.02.048_bib0018","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2026.02.048_bib0019","doi-asserted-by":"crossref","first-page":"r1928","DOI":"10.1136\/bmj-2025-084950","article-title":"Diagnosis and management of metabolic dysfunction associated steatotic liver disease","volume":"391","author":"Musso","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2026.02.048_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083735","article-title":"Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial","volume":"389","author":"Lin","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2026.02.048_bib0021","article-title":"Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients","author":"Wu","year":"2025","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2026.02.048_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71231-7","article-title":"Discontinuation rates, clinical effects and provocation factors of SGLT-2 inhibitor in the real world","volume":"14","author":"Bak","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.amjmed.2026.02.048_bib0023","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12020-025-04393-7","article-title":"Risk of genitourinary tract infections with SGLT-2 inhibitors in type 2 diabetes mellitus: a meta-analysis of randomised controlled trials and disproportionality analysis using FAERS","volume":"90","author":"Yoosuf","year":"2025","journal-title":"Endocrine"},{"issue":"16","key":"10.1016\/j.amjmed.2026.02.048_bib0024","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2024.01.040","article-title":"Genitourinary tract infections in patients taking SGLT2 inhibitors: JACC review topic of the week","volume":"83","author":"Kittipibul","year":"2024","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:27:08Z","timestamp":1779769628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293432600149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S000293432600149X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.02.048","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2025","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.02.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}